Icotinib Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: Conmana

Pipeline

Phase 2: 2

Top Sponsors

Sun Yat-sen University1
Peking University Cancer Hospital & Institute1

Indications

Lung Cancer2
Cancer2
EGFR S768I1
EGFR L861Q1
EGFR G719X1

Other2 trials

A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

Phase 2

Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.